搜索





搜索





市场行情
/
股票
/
inbx
/

Inhibrx Biosciences Inc

INBX

添加自选

82.050USD

-2.680-3.16%

收盘 07-31 16:00（美东）报价延迟15分钟

1.20B总市值

亏损市盈率 TTM

Inhibrx Biosciences Inc

82.050

-2.680-3.16%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

INBX 利润表

您可以在这里找到Inhibrx Biosciences Inc的年度或季度收入报告，以深入了解Inhibrx Biosciences Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

营业总收入

----

-100.00%0.00

--0.00

1200.00%1.30M

----

-93.88%100.00K

-100.00%0.00

233.33%100.00K

-100.00%0.00

496.35%1.63M

-57.19%119.00K

-95.78%30.00K

-98.17%17.00K

-90.41%274.00K

-89.02%278.00K

-25.47%711.00K

4.50%929.00K

2.88%2.86M

-57.09%2.53M

-71.43%954.00K

1.95%889.00K

--2.78M

--5.90M

4.05%3.34M

-89.77%872.00K

14.16%3.21M

205.05%8.52M

--2.27M

--722.00K

--2.81M

--2.79M

营业收入

----

-100.00%0.00

----

1200.00%1.30M

----

-93.88%100.00K

-100.00%0.00

233.33%100.00K

----

496.35%1.63M

-57.19%119.00K

-95.78%30.00K

-98.17%17.00K

-90.41%274.00K

-89.02%278.00K

-25.47%711.00K

4.50%929.00K

2.88%2.86M

-57.09%2.53M

-71.43%954.00K

1.95%889.00K

--2.78M

--5.90M

4.05%3.34M

-89.77%872.00K

14.16%3.21M

205.05%8.52M

--2.27M

--722.00K

--2.81M

--2.79M

营业费用

-27.91%30.93M

-38.19%30.92M

-27.75%33.81M

-82.18%28.69M

-41.89%42.90M

-44.37%50.03M

1.85%46.80M

289.18%161.00M

68.62%73.83M

151.36%89.92M

51.73%45.95M

17.17%41.37M

46.21%43.78M

60.71%35.77M

41.94%30.28M

70.12%35.31M

53.99%29.95M

11.95%22.26M

-0.59%21.33M

1.21%20.75M

5.22%19.45M

--19.88M

--21.46M

48.49%20.51M

52.35%18.48M

45.61%13.81M

3.78%12.13M

--6.35M

--10.58M

--9.48M

--11.69M

研发费用

-31.97%24.69M

-26.25%24.17M

-26.87%27.96M

-67.76%21.68M

-42.94%36.29M

-59.95%32.78M

1.16%38.23M

98.61%67.26M

71.19%63.59M

170.95%81.84M

53.13%37.80M

14.18%33.86M

50.79%37.15M

62.26%30.20M

33.53%24.68M

65.67%29.66M

49.88%24.64M

5.36%18.61M

-6.82%18.48M

-5.65%17.90M

-3.40%16.44M

--17.67M

--19.84M

55.86%18.97M

59.55%17.02M

43.31%12.17M

-1.06%10.66M

--4.68M

--9.50M

--8.49M

--10.78M

折旧摊销及损耗

-20.44%537.00K

71.99%1.19M

-23.29%583.00K

39.08%662.00K

87.50%675.00K

131.21%689.00K

150.00%760.00K

61.36%476.00K

22.03%360.00K

-1.32%298.00K

-1.62%304.00K

-3.91%295.00K

-1.63%302.00K

3.34%309.00K

3.02%307.00K

5.50%307.00K

15.85%307.00K

20.08%299.00K

19.68%298.00K

13.67%291.00K

--265.00K

--249.00K

17.45%249.00K

33.33%256.00K

28.48%212.00K

27.15%192.00K

--199.00K

--161.00K

--165.00K

--151.00K

营业利润

27.91%-30.93M

38.06%-30.92M

27.75%-33.81M

82.98%-27.39M

41.89%-42.90M

43.45%-49.93M

-2.12%-46.80M

-289.22%-160.90M

-68.68%-73.83M

-148.70%-88.29M

-52.74%-45.83M

-19.49%-41.34M

-50.83%-43.77M

-82.95%-35.50M

-59.58%-30.00M

-74.72%-34.60M

-56.36%-29.02M

-13.43%-19.40M

-20.84%-18.80M

-15.34%-19.80M

-5.38%-18.56M

---17.11M

---15.56M

-61.94%-17.17M

-387.57%-17.61M

-58.86%-10.60M

59.40%-3.61M

---4.08M

---9.86M

---6.67M

---8.90M

净非营业利息收入（费用）

利息收入

-56.76%1.01M

-34.45%1.31M

-38.35%1.78M

-22.51%2.12M

-29.51%2.33M

-57.35%2.00M

24.44%2.89M

13.55%2.74M

--3.30M

--4.70M

--2.32M

--2.41M

----

利息费用

30.49%3.51M

--3.19M

--3.18M

-41.41%3.14M

-66.92%2.69M

-100.00%0.00

-32.18%5.36M

60.04%8.13M

53.84%8.22M

52.60%8.15M

151.11%7.91M

123.39%5.08M

200.45%5.34M

200.34%5.34M

244.42%3.15M

205.23%2.27M

234.40%1.78M

-59.85%1.78M

-73.16%914.00K

-69.60%745.00K

--532.00K

--4.43M

594.90%3.41M

892.31%2.45M

26.29%490.00K

-45.23%247.00K

--297.00K

--344.00K

--388.00K

--451.00K

特殊收入（费用）

----

--0.00

-100.00%0.00

----

--0.00

--2.02B

----

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---24.00K

--2.69M

---41.00K

----

--0.00

----

其他非经营性收入（费用）

76.00%-12.00K

-165.00%-39.00K

-212.20%-46.00K

-845.45%-246.00K

15.25%-50.00K

137.97%60.00K

130.37%41.00K

115.21%33.00K

15.71%-59.00K

-122.54%-158.00K

-850.00%-135.00K

-1376.47%-217.00K

-289.19%-70.00K

-1083.33%-71.00K

1900.00%18.00K

240.00%17.00K

131.25%37.00K

14.29%-6.00K

---1.00K

200.00%5.00K

60.00%16.00K

---7.00K

--0.00

-225.00%-5.00K

-16.67%10.00K

-66.67%4.00K

-57.14%12.00K

--14.00K

--12.00K

--28.00K

税前利润

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

47.96%-47.87M

15.30%-43.86M

4049.27%1.86B

-60.91%-78.71M

-124.79%-91.97M

-46.60%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.92M

-71.65%-35.33M

-82.17%-37.73M

-62.05%-31.25M

-20.08%-21.19M

-2.85%-20.58M

-15.80%-20.71M

4.01%-19.29M

---17.65M

---20.01M

-61.32%-17.89M

-422.30%-20.09M

-57.28%-11.09M

58.72%-3.85M

---4.37M

---10.19M

---7.05M

---9.32M

所得税

--0.00

0.00%2.00K

--0.00

100.00%0.00

-100.00%0.00

-60.00%2.00K

----

-300.00%-4.00K

--2.00K

25.00%5.00K

--0.00

---1.00K

--0.00

--4.00K

-100.00%0.00

--0.00

--2.00K

--3.00K

--0.00

100.00%0.00

--0.00

---2.00K

--0.00

--46.00K

--50.00K

--0.00

除税后的权益收益

----

---1.63M

----

--0.00

100.00%0.00

----

--0.00

---487.00K

----

除税后利润

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

47.96%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-124.78%-91.97M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-2.85%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.01M

-61.34%-17.89M

-422.30%-20.09M

-57.26%-11.09M

58.72%-3.85M

---4.41M

---10.24M

---7.05M

---9.32M

持续经营利润

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.50M

-61.34%-17.89M

-422.30%-20.09M

-57.26%-11.09M

58.72%-3.85M

---4.41M

---10.24M

---7.05M

---9.32M

归属少数股东的净利润

----

--0.00

100.00%0.00

--0.00

---142.00K

---453.00K

归属于母公司的净利润

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.50M

-61.34%-17.89M

-422.30%-20.09M

-54.90%-11.09M

58.88%-3.85M

---4.41M

---10.24M

---7.16M

---9.36M

归属于普通股东的净利润

22.79%-33.44M

31.40%-32.83M

19.62%-35.26M

-101.54%-28.65M

44.97%-43.31M

48.86%-47.87M

15.30%-43.86M

4048.85%1.86B

-60.91%-78.71M

-128.78%-93.60M

-46.61%-51.79M

-24.70%-47.05M

-56.51%-48.92M

-93.10%-40.91M

-71.65%-35.33M

-82.19%-37.73M

-62.03%-31.25M

-20.06%-21.19M

-0.40%-20.58M

-15.80%-20.71M

4.00%-19.29M

---17.65M

---20.50M

-61.34%-17.89M

-422.30%-20.09M

-54.90%-11.09M

58.88%-3.85M

---4.41M

---10.24M

---7.16M

---9.36M

基本每股收益

23.37%-2.15

31.67%-2.11

19.68%-2.28

-101.46%-1.85

-94.07%-2.80

-78.82%-3.09

-158.18%-2.84

11888.42%127.10

-28.53%-1.44

-83.08%-1.73

-21.48%-1.10

-11.55%-1.08

-40.14%-1.12

-72.06%-0.94

-66.47%-0.90

-76.52%-0.97

-56.71%-0.80

-17.36%-0.55

0.08%-0.54

-12.23%-0.55

6.74%-0.51

---0.47

---0.54

-61.35%-0.49

-422.29%-0.55

-54.90%-0.30

58.88%-0.10

---0.12

---0.28

---0.20

---0.26

稀释每股收益

23.37%-2.15

31.67%-2.11

19.68%-2.28

-101.48%-1.85

-94.07%-2.80

-78.82%-3.09

-158.18%-2.84

11738.74%125.48

-28.53%-1.44

-83.08%-1.73

-21.48%-1.10

-11.55%-1.08

-40.14%-1.12

-72.06%-0.94

-66.47%-0.90

-76.52%-0.97

-56.71%-0.80

-17.36%-0.55

0.08%-0.54

-12.23%-0.55

6.74%-0.51

---0.47

---0.54

-61.35%-0.49

-422.29%-0.55

-54.90%-0.30

58.88%-0.10

---0.12

---0.28

---0.20

---0.26

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Inhibrx Biosciences Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 INBX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Inhibrx Biosciences Inc 财年末的营收是多少？



Inhibrx Biosciences Inc 2025 财年营收为 1.30M，高于上一财年的200.00K。

Inhibrx Biosciences Inc 全年的净利润是多少？



Inhibrx Biosciences Inc 2025 财年净利润为 -140.06M。

Inhibrx Biosciences Inc 上一季度的净利润是多少？



Inhibrx Biosciences Inc 最近一个季度的净利润为 -33.44M。

Inhibrx Biosciences Inc 年度营业利润是多少？



Inhibrx Biosciences Inc 2025 财年的营业利润为 -135.03M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。